How many shares of VRTX does Candriam S.C.A. own?

As of 2026-Q2, Candriam S.C.A. holds 199,505 shares of VRTX (VERTEX PHARMACEUTICALS INC).

What is Candriam S.C.A.'s VRTX position worth?

As of 2026-Q2, Candriam S.C.A.'s VRTX position is worth $99M.

In 2026-Q2, Candriam S.C.A. decreased their VRTX position (-12.8% change in shares).

Based on available 13F filings, Candriam S.C.A. first reported a position in VRTX in 2019-Q1. They have held the position across 30 quarters.

Position history for Candriam S.C.A.'s holdings in VERTEX PHARMACEUTICALS INC

Current Value

$99M

Current Shares

199,505

Total Value Change

-$22.7M

Total Shares Change

-462,015

Quarter-by-Quarter History

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2026-Q2 Latest	Decreased	199,505	-12.8%	$99M	0.4%	$496.73	0
2026-Q1	Increased	228,915	+1.6%	$102.2M	0.5%	$474.27	43
2025-Q4	Increased	225,292	+29.1%	$102.1M	0.5%	$453.74	53
2025-Q3	Decreased	174,567	-1.0%	$68.4M	0.4%	$395.31	0
2025-Q2	Decreased	176,398	-11.0%	$78.5M	0.5%	$441.30	0
2025-Q1	Decreased	198,287	-23.3%	$96.1M	0.6%	$492.69	0
2024-Q4	Decreased	258,622	-16.9%	$104.1M	0.6%	$399.35	0
2024-Q3	Decreased	311,307	-5.2%	$144.8M	0.8%	$462.88	0
2024-Q2	Decreased	328,271	-15.5%	$153.9M	0.9%	$468.72	0
2024-Q1	Increased	388,588	+13.6%	$162.4M	1.0%	$418.01	54
2023-Q4	Decreased	342,086	-11.0%	$139.2M	1.0%	$406.89	0
2023-Q3	Decreased	384,331	-3.1%	$133.6M	0.9%	$347.74	0
2023-Q2	Increased	396,562	+1.4%	$139.6M	1.0%	$348.18	48
2023-Q1	Decreased	390,908	-16.7%	$113.4M	0.8%	$312.16	0
2022-Q4	Decreased	469,145	-3.2%	$135.5M	0.9%	$288.78	0
2022-Q3	Increased	484,539	+3.6%	$140.3M	1.0%	$292.80	44
2022-Q2	Decreased	467,883	-1.3%	$131.8M	1.1%	$280.35	0
2022-Q1	Decreased	474,253	-26.4%	$123.8M	0.8%	$256.52	0
2021-Q4	Increased	644,632	+8.7%	$141.6M	0.9%	$222.45	46
2021-Q3	Decreased	592,829	-26.6%	$107.5M	0.7%	$182.22	0
2021-Q2	Increased	807,867	+3.6%	$162.9M	1.1%	$196.78	50
2021-Q1	Increased	779,546	0.0%	$177M	1.5%	$212.99	48
2020-Q4	Increased	779,539	+39.7%	$184.2M	1.5%	$232.68	64
2020-Q3	Increased	558,131	+2.2%	$151.9M	1.4%	$270.31	49
2020-Q2	Decreased	546,191	-24.7%	$158.6M	1.7%	$285.18	0
2020-Q1	Unchanged	725,361	0.0%	$155.3M	1.7%	$231.92	0
2019-Q4	Decreased	725,361	-22.1%	$158.8M	1.7%	$218.97	0
2019-Q3	Decreased	930,999	-1.0%	$157.7M	2.1%	$166.74	0
2019-Q2	Increased	940,506	+42.2%	$171.7M	2.1%	$183.38	70
2019-Q1	New	661,520	-	$121.7M	1.6%	$183.95	69